Acute effects of acarbose on post-prandial glucose and triglycerides in type 2 diabetics following intake of different Malaysian foods

Asia Pacific Journal of Clinical Nutrition

Volumn 9, Issue 1, 2000, Pages 41-45

  Nawawi, Hapizah Mohd ^a,b   Yazid, Tengku Norita ^a   Ismail, Faridah ^b   Khalid, B Abdul Kadir ^b  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^b DEPARTMENT OF PHARMACOLOGY   (Malaysia)

Author keywords

Acarbose; Alpha glucosidasc inhibitor; Glucose; Postprandial; Triglyceride; Type 2 diabetes

Indexed keywords

EID: 24044513689     PISSN: 09647058     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-6047.2000.00135.x     Document Type: Article

References (16)

1. Lardinois CK, Greenfield MS, Schwartz HC, Vreman HJ, Reaven GM. Acarbose treatment of non-insulin dependent diabetes mellitus. Arch Intern Med 1984; 114: 345-347.
2. Yamashita K, Sugawara S, Sakairi I. Effects of an alpha-glucosidase inhibitor, acarbose, on blood glucose and serum lipids in streptozocin-induced diabetic rats. Horm Metab Res 1984; 16: 179-182.
3. Reaven GM, Lardinois CK, Greenfield MS, Schwartz HC, Vreman HJ. Effects of acarbose on carbohydrate and lipid metabolism in Type 2 diabetic patients poorly controlled by sulphonylureas. Dia-betes Care 1990; 13 (Suppl.): 32-36.
4. Rodger NW, Chiasson JL, Josse RG, Hunt JA, Palmason C, Ross SA, Ryan EA, Tan MH, Wolever TM. Clinical experience with acarbose: results of a Canadian multicentre study. Clin Invest Med 1995; 18: 318-324.
5. Coniff RF, Shapiro JA, Robbins D, Kleinfield R, Seaton TB, Beisswenger P, McGill JB. Reduction of glycosylated haemoglobin and PPH by acarbose in patients with type 2 diabetes. A placebo-controlled dose-comparison study. Diabetes Care 1995; 18: 817-824.
6. Bayraktar M, Van Thiel DH, Adalar N. A comparison of acarbose versus metformin as an adjuvant therapy in sulphonylurea-treated Type 2 diabetic patients. Diabetes Care 1996; 19: 252-254.
7. Costa B, Pinol C. Acarbose in ambulatory treatment of non-insulin dependent diabetes mellitus associated to imminent sulphonylurea failure: a randomised-multicentre trial in primary health-care. Diabetes Res Clin Pract 1997; 38: 33-40.
8. Bischoff H. The mechanism of alpha-glucosidase inhibition in the management of diabetes. Clin Invest Med 1995; 18: 303-311.
9. Walter-Sack IE, Wolfram G, Zollner N. Effects of acarbose on serum lipoproteins in healthy individuals during prolonged administration of a fiber-free formula diet. Ann Nutr Metab 1989; 33: 100-107.
10. Leonhardt W, Hanefeld M, Fischer S, Schulze J, Spengler M. Beneficial effects of serum lipids in non-insulin dependent diabetics by acarbose treatment. Arzneimittelforschung 1991; 41: 735-738.
11. Pichard F, Deshaies Y. Post-prandial serum lipids and tissue lipoprotein lipase are acutely altered in rats by the alpha-glucosidase inhibitor acarbose. Horm Met Res 1996; 28: 377-380.
12. Khalid BAK, Lee LF, Samad AB, Ng ML. Glycaemic and insulin responses of diabetic patients to traditional Malaysian meals and the effect of guar gum. Asia Pacific J Clin Nutr 1996; 5: 239-243.
13. Hanefeld M, Temelkova-Kurktschiev T. The post-prandial state and the risk of atherosclerosis. Diabet Med 1997; 14: S6-S11.
14. Schrezenmeir J, Keppler I, Fenselau S, Weber P, Biesalski HK, Probst R, Schrezenmein J, Keppier I, Fenselau S, Weber P, Biesalski HK, Probst R, Laue C, Zuchhold HD, Prellwitz W, Beyer J. The phenomenon of a high TG response to an oral lipid load in healthy subjects and its link to the Metabolic Syndrome. Ann N Y Acad Sci 1993; 683: 302-314.
15. Lewis GF, O'Meara NM, Soltys PA. Fasting hypertriglyceridaemia in non-insulin dependent diabetes melitus is an important predictor of postprandial lipid and lipoprotein abnormalities. J Clin Endocrinol Metab 1991; 72: 934-044.
16. Tan KC, Cooper MB, Ling KL, Griffin BA, Freeman DJ, Packard CJ, Shepherd J, Hales CN, Betteridge DJ. Fasting and postprandial non-insulin-dependent diabetic patients with and without hypertriglyceridaemia: the involvement of insulin, insulin precursor species and insulin resistance. Atherosclerosis 1995; 113: 273-287.